| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
25,920,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Metacrine is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with gastrointestinal, or GI, diseases. Co.'s program, MET642, targets the farnesoid X receptor, or FXR, which is central to modulating GI and liver diseases. Co. is developing another FXR agonist, MET409, for the treatment of non-alcoholic steatohepatitis, or NASH, a liver disease characterized by excess liver fat, inflammation and fibrosis. Co. is also developing small molecule inhibitors of hydroxysteroid dehydrogenase 17b13, or HSD17ss13, for the treatment of NASH. HSD17ss13 is a genetically validated target for liver disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,510,570 |
| Total Buy Value |
$0 |
$0 |
$0 |
$936,096 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
487,659 |
| Total Sell Value |
$0 |
$0 |
$0 |
$201,597 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nea 16 Gp, Llc |
10% Owner |
– – • |
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
D/D |
(459,700) |
2,563,257 |
|
- |
|
| Florence Anthony A. Jr. |
10% Owner |
– – • |
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
I/I |
(459,700) |
2,563,257 |
|
- |
|
| Baskett Forest |
10% Owner |
– – • |
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
I/I |
(459,700) |
2,563,257 |
|
- |
|
| Walker Paul Edward |
10% Owner |
– – • |
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
I/I |
(459,700) |
2,563,257 |
|
- |
|
| Behbahani Ali |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
I/I |
(37,570) |
3,022,957 |
|
- |
|
| Chang Carmen |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
I/I |
(37,570) |
3,022,957 |
|
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
I/I |
(37,570) |
3,022,957 |
|
- |
|
| Makhzoumi Mohamad |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
I/I |
(37,570) |
3,022,957 |
|
- |
|
| Sonsini Peter W. |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
I/I |
(37,570) |
3,022,957 |
|
- |
|
| Nea 16 Gp, Llc |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
D/D |
(37,570) |
3,022,957 |
|
- |
|
| Florence Anthony A. Jr. |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
I/I |
(37,570) |
3,022,957 |
|
- |
|
| Baskett Forest |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
I/I |
(37,570) |
3,022,957 |
|
- |
|
| Walker Paul Edward |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
I/I |
(37,570) |
3,022,957 |
|
- |
|
| Adelman Robert J |
10% Owner |
– – • |
2021-10-25 |
4 |
S |
$1.49 |
$805,972 |
D/D |
(540,667) |
2,443,421 |
|
- |
|
| Adelman Robert J |
10% Owner |
– – • |
2021-10-22 |
4 |
S |
$1.64 |
$122,930 |
D/D |
(75,035) |
2,984,088 |
|
- |
|
| Chen Hubert C |
Chief Medical Officer |
• – – |
2021-05-20 |
4 |
B |
$3.60 |
$11,840 |
D/D |
3,289 |
3,289 |
2.74 |
- |
|
| Klassen Preston |
President & CEO |
• • – |
2021-05-20 |
4 |
B |
$3.64 |
$74,692 |
D/D |
20,547 |
20,547 |
2.81 |
- |
|
| Lee Catherine Chai-Zon |
EVP, Gen. Counsel & Secretary |
• – – |
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,846 |
3,846 |
|
- |
|
| Millican Trisha |
Chief Financial Officer |
• – – |
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
759 |
41,792 |
|
- |
|
| Chang Carmen |
10% Owner |
– – • |
2020-09-18 |
4 |
B |
$13.00 |
$9,999,990 |
I/I |
769,230 |
3,060,527 |
1.5 |
- |
|
| Chang Carmen |
10% Owner |
– – • |
2020-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,291,297 |
2,291,297 |
|
- |
|
| Millican Trisha |
Chief Financial Officer |
• – – |
2020-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
9,803 |
67,248 |
|
- |
|
| Nashat Amir |
Director |
– • • |
2020-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,664,258 |
178,942 |
|
- |
|
| Nashat Amir |
Director |
– • • |
2020-09-18 |
4 |
B |
$13.00 |
$2,990,000 |
I/I |
230,000 |
15,038 |
2.25 |
- |
|
| Polaris Partners Vii, L.p. |
10% Owner |
– – • |
2020-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,664,258 |
178,942 |
|
- |
|
84 Records found
|
|
Page 2 of 4 |
|
|
